Article
Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer
2026-08-06
Abstract excerpt
Despite the clinical success of immune checkpoint inhibitors (ICIs) in the management of advanced clear cell renal cell carcinoma (ccRCC), many tumors develop acquired resistance, presumed to arise from a refractory subpopulation of persister cancer cells. Previous studies have provided insights into tumor microenvironment-specific drivers of ICI resistance in ccRCC. However, the extent to which ccRCC cells underg...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 037b13ad-9bd8-5d23-a0cc-011d18881a4a
- DOI
- 10.64898/2026.08.05.743137
